Home›Companies›Healthcare›Accure Acne

Accure Acne, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 25, 2025·Suggest an edit

About Accure Acne

Accure Acne is a private company based in Boulder, Colorado. It has reported $29,518,114 raised in four offerings on Form D since March 2017.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 26, 2023Feb 8, 2023amended Nov 25, 2025$21,782,114of $24.0M target106$205KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Apr 4, 2022Apr 19, 2022$3,500,000of $5.0M target12$291KEquity, Debt, Securities on exerciseRule 506(b)Form D ↗
Sep 29, 2021Oct 8, 2021$2,011,000of $20.0M target20$100KEquityRule 506(c)Form D ↗
Feb 22, 2017Mar 8, 2017amended May 30, 2017$2,225,000fully sold13$171KDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Total, four offerings$29,518,114

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Accure Acne's Form D filed Nov 25, 2025.

Samuel Navarro
Samuel Navarro
Director
Also COO and director at PECA Labs.
KN
Karl Nicholls
Chief Financial Officer
CC
Christopher Carlton
Executive officer and director
EB

Earlier filings also listed A. Barbera (director, last listed Apr 2022), R. Anderson (executive officer, last listed May 2017) and Craig Drill (director, last listed May 2017).

Sources

  1. SECAccure Acne, Inc. Form D/A, filed Feb 8, 2024
  2. SECAccure Acne, Inc. Form D, filed Feb 8, 2023
  3. SECAccure Acne, Inc. Form D, filed Mar 8, 2017
  4. SECAccure Acne, Inc. filing history